Jump to content

New Podcasts on Smoking Cessation and Lung Cancer Highlights


Guest LCSC Info

Recommended Posts

Guest LCSC Info

New Podcasts on Smoking Cessation and Lung Cancer Highlights of 2011

March 16th, 2012 - by Dr. Jack West

http://blog.lungevity.org/2012/03/16/ne ... s-of-2011/

Here are a pair of podcasts completed several months ago. The first is by Dr. Mark Millard, Professor of Pulmonology at Baylor University and Medical Director of the Martha Foster Lung Care Center in Dallas, TX. In an exhaustive discussion, he covers how physicians can effectively discuss quitting with patients and how someone motivated to quit can use a wide range of tools to improve their chance of cure.

Click on the blog link above to find the podcast in both audio and video formats along with the transcript and figures for the program.

Dr. Millard Tips and Tools for Smoking Cessation Video Podcast

Dr. Millard Tips and Tools for Smoking Cessation Audio Podcast

Dr. Millard Tips and Tools for Smoking Cessation Transcript

Dr. Millard Tips and Tools for Smoking Cessation Figures

The second podcast I’d like to introduce now is the first part of Dr. Weiss’s summary of the highlights in the field of lung cancer in 2011. Because he covered so much ground in this presentation, we’ve divided it into several short pieces covering a few issues at a time. In fact, we’ll plan to produce our podcasts as shorter, easier to digest pieces in the future.

This first part covers therapies centered on the EGFR axis, including the EURTAC trial of the EGFR tyrosine kinase inhibitor (TKI) Tarceva (erlotinib) vs. conventional chemotherapy in European patients with advanced NSCLC and an activating EGFR mutation. This is followed by his summary of two different combinations of EGFR TKI and monoclonal antibody: one is the single-arm trial of afatinib with Erbitux (cetuximab) for patients with acquired resistance to EGFR TKI therapy after a good response, while the second is a randomized phase II trial of Tarceva with either MET-MAb, a monoclonal antibody against the target c-MET, or placebo.

Click on the blog link above to find the audio and video versions of the podcast, as well as the transcript and figures for the program.

Dr. Weiss Lung Cancer Highlights 2011 Pt 1 EGFR Axis Video Podcast

Dr. Weiss Lung Cancer Highlights 2011 Pt 1 EGFR Axis Audio Podcast

Dr. Weiss Lung Cancer Highlights 2011 Pt 1 EGFR Axis Transcript

Dr. Weiss Lung Cancer Highlights 2011 Pt 1 EGFR Axis Figs

We’ll have more pieces of this podcast available here very soon. I hope you find these podcast programs helpful.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.